Unlock instant, AI-driven research and patent intelligence for your innovation.

Methods of enhancing stem cell differentiation into beta cells

A technology of cells and cell populations, applied in chemical instruments and methods, biochemical equipment and methods, receptors/cell surface antigens/cell surface determinants, etc.

Pending Publication Date: 2020-12-11
VERTEX PHARMA INC
View PDF32 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This initiative could make patients transplanted with cadaveric human islets insulin-independent for 5 years or more, but this approach is limited by the scarcity and quality of donor islets

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods of enhancing stem cell differentiation into beta cells
  • Methods of enhancing stem cell differentiation into beta cells
  • Methods of enhancing stem cell differentiation into beta cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0656] Example 1. Histone acetylation in hPSC-derived beta cells

[0657] A systematic approach (e.g., Arda et al. (Cell Metabolism 23:909-920, 2016)) was used to identify age-related gene expression programs in human pancreatic islets, which included (1) obtaining pancreatic tissue from children and adults; (2) developing robust and reliable cell purification methods; (3) generation of complete transcriptome and histone modification profiles; and (4) systematic analysis of islet physiology and function. Distinct patterns of histone-mediated age-related gene regulation in juvenile and adult human islets are revealed on the genome-wide histone atlas. Xu et al. (EMBO J 2014) describe decreased histone methylation of NGN3, NKX6.1 and NKX2.2 genes in endocrine progenitor cells. In NGN3 cells, H3K27me3 was deleted from NGN3, NeuroD1, and NKX6.1 elements, consistent with activation of individual genes. Haumaitre et al. (MCB 2013) reported a general decrease in HDAC expression and ...

Embodiment 2

[0658] Example 2. Inhibition of Histone Methylation and Deacetylation

[0659] NGN3 mRNA expression was studied at each step of directed differentiation described here ( Figure 5 ), and cells were observed to express NGN3 to trigger SC-β cell differentiation ( Figure 7 ). The effect of inhibition of histone methylation and deacetylation on SC-β cell differentiation was investigated ( Figure 6 ). With EZH2 inhibitor (DZNep), HDAC inhibitor (KD5170) and their combination ( Figure 6 ) to stage 5 of the directed differentiation described herein for hESC lines (D97, D114 and D241 HUES8) ( Figure 5-Figure 6 ).

[0660] Such as Figure 18 Screening of candidate inhibitors was performed as indicated. Inhibition of EZH2 or HDAC in stage 5 (D97 HUES8) increased endocrine cells and SC-β cells ( Figure 8 ). Combined inhibition of EZH2 and HDAC at stage 5 (D114 HUES8) significantly increased endocrine cells ( Figure 9-Figure 11 ). At the end of phase 5, with DZNep and KD5...

Embodiment 3

[0663] Example 3. Differentiation of Stem Cells to Pancreatic β Cells (SC-β Cells)

[0664] Such as Figure 39 As shown, two exemplary differentiation protocols v11 and v12 were tested. Both protocols are 6-stage stepwise protocols sharing similar reagents, and their first 5 stages of differentiation steps are largely based on Figure 5 The differentiation schemes shown, and their differences are as follows: (a) In the v12 scheme, 0.25 μM DMH-1 was present in the medium of stage 3 day 1 (S3d1), and at stage 3 day 1 and Activin A was present at 20 ng / mL in the medium on day 2 (S3d1-S3d2); (b) in the v11 protocol, no DMH-1 or activin A was added in stage 3; (c) in the v11 and v12 protocols , DZNep was present at 100 nM in the culture medium on days 1, 3, 5, and 7 of stage 5. Stage 6 of both the v11 and v12 protocols was performed by culturing the product cells of stage 5 in DMEM / F12 medium supplemented with 1% HAS without exogenous differentiation factors. Throughout Stage 6...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

Disclosed herein are compositions and methods of enhancing stem cell differentiation into beta cells with use of one or more epigenetic modification compounds. The present disclosure also relates to compositions and methods of sorting and enriching the differentiated beta cells. The present disclosure also relates to compositions and methods of irradiating cell population for reducing proliferation.

Description

[0001] cross reference [0002] This application claims the benefit of U.S. Provisional Application No. 62 / 637,923, filed March 2, 2018, which is hereby incorporated by reference in its entirety. Background technique [0003] Deciphering the molecular mechanisms that guide islet cell regeneration, fitness, and function could improve and expand beta-cell replacement strategies for the treatment of diabetes. Generation of stem cell-derived beta cells may provide a potentially useful step in the generation of islets and pancreatic organoids. One of the rapidly growing diseases that can be treated by stem cell-derived tissues is diabetes. Type 1 diabetes results from autoimmune destruction of beta cells in the pancreatic islets. Type 2 diabetes results from peripheral tissue insulin resistance and β-cell dysfunction. Diabetics, especially those with type 1 diabetes, can be cured by transplanting new beta cells. This initiative could make patients transplanted with cadaveric h...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/39A61P3/10C07K14/72C12N5/00C12N5/071C12N5/077
CPCA61P3/08C07K14/72A61K35/39C12N5/0676C12N2501/065C12N2501/999C12N2501/16C12N2501/155C12N2506/02C12N9/1007C12N9/1029C12N2501/11C12N2501/15
Inventor 费利西亚·帕柳卡乔治·哈伯马斯·居特勒詹森·加利亚柏叶军莉莲·叶奥斯汀·蒂尔吉哈德·亚辛埃夫雷特·汤普森
Owner VERTEX PHARMA INC